Written and maintained by CASRAI Editorial Board
Published
On this page
Neuroethics is the consideration of the ethical, legal and societal implications of neuroscience research and of the tools and technologies it produces. In practice it is applied through published governance frameworks, most prominently the neuroethics guiding principles of the US NIH BRAIN Initiative (eight principles, 2018) and the OECD Recommendation on Responsible Innovation in Neurotechnology (nine principles, adopted December 2019). This guide sets out what each framework says and what it asks of research teams.
What is neuroethics?
The NIH BRAIN Initiative neuroethics paper by Greely and colleagues, published in the Journal of Neuroscience in December 2018, frames the field as attention to the ethical, legal and societal implications of neuroscience research. It does not offer a formal one-line definition, and neither does the OECD instrument; both are working documents that tell researchers, funders and governments what to attend to. That is the sense in which this page uses the term: a set of questions about safety, autonomy, privacy, misuse and fairness that arise whenever a study records, interprets or alters brain activity.
For the scientific background on the research itself, see what is neuroscience. For a large-scale example of a brain-research programme that raises these questions, see the Human Brain Project.
What does neuroethics cover?
Read together, the two frameworks show the scope in practice. Both start from safety. Both treat the privacy of data about the brain as a distinct concern. Both address people whose capacity to decide may be limited, the possibility of harmful uses of neuroscience tools, public dialogue, and the fair sharing of benefits. The OECD instrument adds oversight capacity, international collaboration and a culture of stewardship, because it addresses governments and innovators as well as laboratories.
The NIH BRAIN Initiative neuroethics guiding principles
Greely HT, Grady C, Ramos KM, Chiong W, Eberwine J, Farahany NA, Johnson LSM, Hyman BT, Hyman SE, Rommelfanger KS and Serrano EE published “Neuroethics Guiding Principles for the NIH BRAIN Initiative” in the Journal of Neuroscience (2018;38(50):10586-10588, DOI 10.1523/JNEUROSCI.2077-18.2018). It lists eight principles, quoted here in the authors’ wording:
- Make assessing safety paramount
- Anticipate special issues related to capacity, autonomy, and agency
- Protect the privacy and confidentiality of neural data
- Attend to possible malign uses of neuroscience tools and neurotechnologies
- Move neuroscience tools and neurotechnologies into medical or nonmedical uses with caution
- Identify and address specific concerns of the public about the brain
- Encourage public education and dialogue
- Behave justly and share the benefits of neuroscience research and resulting technologies
The principles are written for a specific research programme, but they are a usable checklist for any team working with human participants and neural recording or stimulation tools.
The OECD Recommendation on Responsible Innovation in Neurotechnology
The OECD Council adopted the Recommendation (instrument OECD/LEGAL/0457) in December 2019. It defines its key terms, and these definitions are useful for protocols and data policies:
- Neurotechnology: “devices and procedures used to access, monitor, investigate, assess, manipulate, and/or emulate the structure and function of the neural systems of natural persons.”
- Cognitive liberty: “the right to mental self-determination.”
- Personal brain data: “data relating to the functioning or structure of the human brain of an identified or identifiable individual that includes unique information about their physiology, health, or mental states.”
- Safety: “an acceptable level of probable benefits and risks to health.”
The nine principles, by title:
- Promote responsible innovation in neurotechnology to address health challenges
- Prioritise assessing safety in the development and use of neurotechnology
- Promote the inclusivity of neurotechnology for health
- Foster scientific collaboration in neurotechnology innovation across countries, sectors, and disciplines
- Enable societal deliberation on neurotechnology
- Enable the capacity of oversight and advisory bodies to address novel issues in neurotechnology
- Safeguard personal brain data and other information gained through neurotechnology
- Promote cultures of stewardship and trust in neurotechnology across the public and private sector
- Anticipate and monitor the potential unintended use and/or misuse of neurotechnology
NIH BRAIN principles and OECD principles compared
The data table below this guide pairs the two frameworks theme by theme: safety, capacity and consent, neural data privacy, misuse, public dialogue and benefit sharing. Two points stand out. First, safety is the first or second item in both lists, so a protocol that cannot show a safety assessment is weak under either framework. Second, only the OECD text sets out concrete data-subject options and oversight expectations, which the next sections draw on.
Neural data, consent and capacity in research practice
Protecting neural data
NIH principle 3 asks teams to protect the privacy and confidentiality of neural data. OECD principle 7 goes further and, in its sub-points, calls for options for people to access, amend and delete their personal data, and for protecting brain data from discrimination in legal processes, employment and insurance. A data management plan for a study that records brain activity should therefore state how identifiable neural recordings are stored, who can access them, and what participants can request. The general techniques are covered in differential privacy.
Consent and limited decision-making capacity
NIH principle 2 and OECD principle 7 both point to autonomy. The OECD text asks for consent that is adequate to protect autonomy, including for people with limited decision-making capacity. Consent documents for neuroscience studies should be written with that in mind; the standard elements are in components of informed consent.
Oversight bodies
OECD principle 6 asks governments to enable oversight and advisory bodies to address novel issues, to encourage research into the ethical, legal and social dimensions of neurotechnology, and to ensure oversight bodies have multidisciplinary expertise. For institutions, that translates into ethics committees that can call on neuroscience, data protection and ethics expertise when a protocol involves brain recording or stimulation.
Misuse and dual use
NIH principle 4 and OECD principle 9 both ask researchers to anticipate how tools might be misused. Teams can record this in the risk section of a protocol and revisit it when a tool moves from a laboratory setting towards clinical or commercial use, the caution that NIH principle 5 describes.
A practical checklist for research teams
The frameworks do not prescribe procedures, but their principles translate into questions a team can answer in a protocol, a data management plan or an ethics submission:
- Safety: is there a documented assessment of the benefits and risks to health of the recording or stimulation tool, as both frameworks place safety first or second?
- Capacity and autonomy: does the consent process address participants whose decision-making capacity may be limited (NIH principle 2; OECD principle 7)?
- Neural data: does the data plan treat brain recordings from identifiable people as personal brain data, with options to access, amend and delete (OECD principle 7)?
- Misuse: does the risk section consider malign or unintended uses of the tool (NIH principle 4; OECD principle 9)?
- Public dialogue and benefit sharing: is there a plan to engage the public and to share benefits fairly (NIH principles 6 to 8; OECD principle 5)?
Common misunderstandings
- Neuroethics is not a single law. The two frameworks discussed here are guidance: principles and recommendations, not statutes. Binding obligations on consent, data protection and human-subjects review come from the rules that apply to your institution and jurisdiction.
- It is not limited to implants. The OECD definition of neurotechnology covers devices and procedures that access, monitor, investigate, assess, manipulate or emulate neural systems, so recording tools are within scope as well as stimulation.
- Brain data is not automatically anonymous. The OECD definition of personal brain data covers data relating to an identified or identifiable individual.
- It is not only a clinical concern. NIH principle 5 explicitly names nonmedical uses, and OECD principle 9 covers unintended use and misuse.
Ethical review of animal studies follows a different framework; see animal research ethics.
Frequently asked questions
What is neuroethics in simple terms?
Neuroethics is the consideration of the ethical, legal and societal implications of neuroscience research and its tools, according to the NIH BRAIN Initiative neuroethics guiding principles published in 2018.
How many principles are in the NIH BRAIN Initiative neuroethics guidance?
Eight. They begin with making safety paramount and end with behaving justly and sharing the benefits of neuroscience research.
What is the OECD Recommendation on neurotechnology?
It is a Council instrument, OECD/LEGAL/0457, adopted in December 2019, with nine principles on responsible innovation in neurotechnology, from safety assessment to monitoring misuse.
What is personal brain data?
The OECD defines it as data relating to the functioning or structure of the human brain of an identified or identifiable individual that includes unique information about their physiology, health or mental states.
What is cognitive liberty?
In the OECD Recommendation, cognitive liberty is “the right to mental self-determination.”
Are these frameworks legally binding?
They are guidance for researchers, funders and governments. Legal duties on consent and data protection come from the laws and institutional policies that apply to a given study.
Sources
- Greely HT, et al. Neuroethics Guiding Principles for the NIH BRAIN Initiative. J Neurosci. 2018;38(50):10586-10588. DOI 10.1523/JNEUROSCI.2077-18.2018. pmc.ncbi.nlm.nih.gov/articles/PMC6297371 (read 2026-11-14).
- OECD. Recommendation of the Council on Responsible Innovation in Neurotechnology, OECD/LEGAL/0457. legalinstruments.oecd.org/en/instruments/OECD-LEGAL-0457 (text read 2026-11-14).
Data: NIH BRAIN Initiative and OECD neurotechnology principles matched by theme
Each row pairs a theme with the closest principle in the NIH BRAIN Initiative neuroethics guiding principles (2018) and the OECD Recommendation on Responsible Innovation in Neurotechnology (2019); pairings are editorial matches, principle wording is quoted from the two sources.
Period covered: 2018/2019.
| Theme | NIH BRAIN Initiative principle (2018) | OECD Recommendation principle (2019) |
|---|---|---|
| Safety | Make assessing safety paramount | Prioritise assessing safety in the development and use of neurotechnology |
| Capacity, autonomy and consent | Anticipate special issues related to capacity, autonomy, and agency | Principle 7 sub-point (b): consent adequate to protect autonomy, including limited decision-making capacity |
| Privacy of neural data | Protect the privacy and confidentiality of neural data | Safeguard personal brain data and other information gained through neurotechnology |
| Misuse | Attend to possible malign uses of neuroscience tools and neurotechnologies | Anticipate and monitor the potential unintended use and/or misuse of neurotechnology |
| Cautious translation to use | Move neuroscience tools and neurotechnologies into medical or nonmedical uses with caution | Promote responsible innovation in neurotechnology to address health challenges |
| Public concerns and dialogue | Identify and address specific concerns of the public about the brain; Encourage public education and dialogue | Enable societal deliberation on neurotechnology |
| Fair sharing of benefits | Behave justly and share the benefits of neuroscience research and resulting technologies | Promote the inclusivity of neurotechnology for health |
| Oversight capacity | No matching principle | Enable the capacity of oversight and advisory bodies to address novel issues in neurotechnology |
| Collaboration and stewardship | No matching principle | Foster scientific collaboration in neurotechnology innovation across countries, sectors, and disciplines; Promote cultures of stewardship and trust in neurotechnology across the public and private sector |
Sources
- Neuroethics Guiding Principles for the NIH BRAIN Initiative (accessed 2026-11-14)
- OECD Recommendation on Responsible Innovation in Neurotechnology (OECD/LEGAL/0457) (accessed 2026-11-14)
Compiled by CASRAI from the sources above. Free to reuse under CC BY 4.0 with attribution.







